The breast milk transfer question
The concern specific to breastfeeding: could pesticide residue absorbed by the nursing parent during or after treatment transfer to breast milk and reach the infant? This is a legitimate question worth examining, not dismissing. The answer depends on: (1) the specific compound's lipophilicity (fat-soluble compounds transfer more readily to milk, which is high-fat); (2) the dose absorbed; (3) the timing of breastfeeding relative to exposure. For organochlorine pesticides (DDT, chlordane, aldrin — now banned in Canada), breast milk transfer was documented and significant. These were highly persistent, highly lipophilic compounds with long body half-lives. For modern residential actives — synthetic pyrethroids (cypermethrin, deltamethrin), IGRs (pyriproxyfen, hydroprene), borate-based baits — the picture is substantially different. Pyrethroids are rapidly metabolised and excreted; they have short plasma half-lives (hours to 1–2 days) and relatively lower lipophilicity than organochlorines. Studies of occupationally-exposed individuals (agricultural workers, not residential pest control recipients) at much higher doses than residential treatment exposure do not show clinically significant breast milk contamination.
What PMRA assesses for breastfeeding
PMRA product registration for residential use requires reproductive and developmental toxicity studies. The registration assessment considers maternal-to-infant transfer for products likely to result in maternal exposure. For modern residential pyrethroids at registered application rates, the PMRA acceptable daily intake for the general population — already built with a 100× safety factor below the no-effect level — is not expected to be exceeded by residential treatment exposure in any realistic scenario. The nursing infant receives breast milk. The question is whether residue in that milk reaches the infant at a concentration that is meaningful. For pyrethroids at residential application rates: PMRA's assessment, supported by pharmacokinetic modelling, is that breast milk concentrations would be well below any level of toxicological concern even in a worst-case residential exposure scenario.
The precautionary recommendation
- Schedule treatment when the nursing parent is away from home — at work, visiting family, or otherwise absent during treatment and for the re-entry interval.
- Standard 1-hour REI applies; extend to 3 hours as a precautionary step.
- Ensure cross-ventilation during and after treatment before nursing parent returns.
- If scheduling away is not possible: use a bait-only protocol (no liquid interior application) and have the nursing parent in a well-ventilated room away from treatment areas.
- Pump-and-discard is not recommended based on current evidence for standard residential pyrethroid treatment — this level of precaution is not supported by the pharmacokinetic data.
- Communicate the breastfeeding status on booking — this changes scheduling and may change product selection.
When to consult your physician
For most standard residential pest treatments, consultation with your physician before treatment is not necessary if the precautionary protocol above is followed. However, consult your physician or a lactation consultant if: (1) you have a confirmed significant exposure (e.g., you were present during treatment in an unventilated space); (2) you're concerned about a specific product with an unusual active ingredient your physician can advise on; (3) your infant has a pre-existing health condition that increases sensitivity. BC Poison Control (1-800-567-8911) can also advise on specific exposure scenarios. For a standard professional residential treatment where you were away during application and observed the REI: the evidence does not support any additional precautionary measures beyond standard ventilation.